KEWALRAMANI RESHMA (CEO & President) reported 1 transaction at VERTEX PHARMACEUTICALS INC / MA
Review the transaction codes below to understand the nature of each event.
Filed: 2/12/2026ACC: 0000875320-26-000046
DirectorOfficer· CEO & President
Since Feb 2026
-8.30K
Net shares
Net seller
$3.89M
Total sold
0
Open market trades
0B · 0S
1
Total transactions
8.30K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−8.30K
Price / share
$468.41
Trade value
$3.89M
% of position
5.4%
2/10/2026
154.82K→146.53K
Total
Net shares
−8.30K
Net value
-$3.89M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2026 | F · Tax Withholding | −8.30K | $468.41 | $3.89M | 5.4% | 154.82K | 146.53K |
| Total | −8.30K | -$3.89M | ||||||
Derivative Transactions0
No derivative transactions reported